L. Flamigni, H. Langhals, D. T. Gryko et al.
for 24 h. The resulting mixture was diluted with water (20 mL) and 2m
HCl (140 mL) and allowed to sediment for 24 h. The precipitate was col-
lected by vacuum filtration, washed with water, dried, and purified by
column chromatography (silica, CH2Cl2, then CH2Cl2/acetone 98:2). The
second fluorescent fraction was evaporated (mixture of acetal/aldehyde
9:1 based on NMR spectrscopy), the residue was dissolved in CH2Cl2/
TFA/H2O mixture (40:10:1, 51 mL), and stirred for 16 h. Saturated
NaHCO3 was carefully added and the organic phase was separated,
washed with water, dried with Na2SO4, and evaporated. The pure alde-
hyde was obtained after refluxing with MeOH and filtration, red crystals,
540 mg, 16% after 2 steps. M.p.=>2508C; Rf (silica gel, CHCl3/EtOH
40:1)=0.29; 1H NMR (600 MHz, CDCl3, 258C): d=0.82 (t, 3J=7.0 Hz,
6H; 2CH3), 1.28 (m, 16H; CH2), 1.87 (m, 2H; a-CH2), 2.23 (m, 2H; a-
CH2), 5.18 (m, 1H; a-CH), 5.48 (s, 2H; NCH2), 7.70 (d, 3J=8.2 Hz, 2H;
CHarom.), 7.85 (d, 3J=8.3 Hz, 2H; CHarom.), 8.68 (m, 8H; CHarom.),
9.98 ppm (s, 1H; CHO); 13C NMR (125 MHz, CDCl3): d=13.7, 22.3,
26.7, 28.9, 31.5, 32.1, 43.2, 54.6, 122.4, 122.5, 122.9, 126.0, 129.0, 129.1,
129.2, 129.7, 131.2, 134.6, 135.5, 143.5, 162.9, 191.5 ppm; IR (ATR): n˜ =
2953.8 (m), 2923.0 (s), 2855.3 (m), 1697.4 (s), 1646.4 (vs), 1610.0 (m),
1593.4 (s), 1577.3 (m), 1506.9 (w), 1436.2 (m), 1403.9 (m), 1378.2 (w),
1336.1 (s), 1301.7 (w), 1249.8 (m), 1212.4 (w), 1199.7 (w), 1168.2 (m),
1125.2 (w), 1106.0 (w), 987.0 (w), 849.6 (w), 823.9 (w), 808.9 (m), 774.3
(w), 742.6 (m), 723.1 (w), 631.4 cmꢀ1 (w); UV/Vis (CHCl3): lmax (e)=
459.1 (18600), 491.0 (51400), 527.4 nm (85800); fluorescence (CHCl3):
lmax (I)=534.5 (1.00), 578.0 nm (0.50), fluorescence quantum yield
(CHCl3, lexc =491 nm, E491nm =0.0212 cmꢀ1, reference: 2,9-bis-(1-hexyl-
heptyl)anthra[2,1,9-def;6,5,10-d’e’f’]diisoquinoline-1,3,8,10-tetraone with
F=1.00): 1.00; MS (DEI+/70 eV): m/z (%): 690 (33) [M+], 508 (100)
[M+ꢀC13H26], 374 (14), [M+ꢀC21H35O2], 346 (19) [M+ꢀC22H34NO2] , 44
(15) [CH2NO]; HRMS: m/z: calcd: C45H42N2O5: 690.309; found: 690.308;
elemental analysis calcd (%) for C45H42N2O5: C 78.24, H 6.13, N 4.06;
found: C 77.98, H 6.01, N 4.05.
dehyde (14): 9-(1-Hexylheptyl)-2-benzopyrano[6’,5’,4’:10,5,6]anthra[2,1,9-
def]isoquinoline-1,3,8,10-tetraone (4, 400 mg, 0.697 mmol), 4’-(1,3-dioxo-
lan-2-yl)biphenyl-4-methanamine (13, 350 mg, 1.37 mmol)), imidazole
(10.0 g), and a microspatula quantity of zinc acetate (Zn(OAc)2·2H2O)
A
were allowed to react under argon as was described for 5 and the product
was purified and deprotected by column separation (silica gel, chloro-
form/ethanol 40:1). The intensely reddish-orange main fraction was col-
lected after an orange forerun and was evaporated, dissolved in the mini-
mum amount of chloroform, and precipitated with acetonitrile. Bright
light-red solid; yield 440 mg (57%); m.p. >2508C, Rf (silica gel, CHCl3/
EtOH 40:1)=0.28; 1H NMR (600 MHz, CDCl3, 258C, TMS): d=0.82 (t,
3J
(H;H)=7.0 Hz, 6H; 2CH3), 1.18–1.38 (m, 16H; 8CH2), 1.83–1.91
G
(m, 2H; b-CH2), 2.21–2.29 (m, 2H; b-CH2), 5.15–5.22 (m, 1H; a-CH),
5.46 (s, 2H; NCH2), 7.58–7.61 (m, 2H; CHaryl), 7.67–7.72 (m, 4H; CHaryl),
7.91–7.94 (m, 2H; CHaryl), 8.59–8.71 (m, 8H; CHperylene), 10.0 ppm (s, 1H;
CHO); 13C NMR (150 MHz, CDCl3, 258C, TMS): d=14.3, 22.8, 27.2,
29.4, 32.0, 32.6, 43.7, 55.1, 123.2, 123.5, 126.6, 126.8, 127.7, 127.8, 129.7,
129.8, 129.9, 130.5, 132.0, 135.3, 135.4, 137.7, 139.3, 147.0, 163.7,
192.1 ppm; IR (ATR): n˜ =2952.5 (m), 2924.0 (s), 2854.9 (m),1691.9 (s),
1650.2 (vs), 1592.6 (s), 1577.7 (m), 1506.5 (w), 1456.1 (w), 1434.7 (w),
1403.6 (m), 1378.0 (w), 1332.6 (s), 1247.0 (m), 1214.8 (w), 1169.3 (m),
1125.8 (w), 1106.2 (w), 1003.6 (w), 987.8 (w), 849.6 (w), 808.2 (m), 782.0
(w), 748.8 (w), 740.3 (w), 606.5 cmꢀ1 (w); UV/Vis (CHCl3): lmax (e Erel.)=
459.2 (0.22), 490.4 (0.60), 527.0 nm (1.00); fluorescence (CHCl3): lmax
(Irel.)=535.2 (1.00), 576.5 nm (0.50); fluorescence quantum yield (CHCl3,
lexc =490 nm, E490 nm =0.0132 cmꢀ1, reference: 2,9-bis-(1-hexylheptyl)an-
thra[2,1,9-def;6,5,10-d’e’f’]diisoquinoline-1,3,8,10-tetraone with F=1.00):
1.00; MS (DEI+/70 eV): m/z (%): 766 (21) [M+], 584 (100) [M+
ꢀC13H26], 346 (55) [M+ꢀC28H38NO2], 195 (14) [C14H11O]; HRMS
(C53H50N2O6): m/z: calcd: 766.340; found: 766.339.
10-[(4-[9-(1-Hexylheptyl)-1,3,8,10-tetraoxo-3,8,9,10-tetrahydro-1H-
anthra[2,1,9-def;6,5,10-d’e’f’]diisoquinoline-2-ylmethyl]phenyl)]-5,15-
bis(2,6-dichlorophenyl)corrole (C2-PI): 2,6-Dichlorophenyldipyrrome-
thane 15 (232 mg, 0.8 mmol) and aldehyde 5 (276 mg, 0.4 mmol) were
dissolved in CH2Cl2 (6 mL). TFA (12 mL, 0.16 mmol) was added and mix-
ture was stirred at RT for 20 min. Et3N (22 mL, 0.16 mmol) was added
followed by p-chloranil (296 mg, 1.2 mmol) and stirring was continued
for 16 h. The reaction mixture was concentrated and was purified by
chromatography (DCVC, silica, CH2Cl2). After evaporation, the residue
was dissolved in THF and loaded on an SEC column (THF). The corrole
fraction was collected, evaporated, refluxed with MeOH, and filtered to
afford 70 mg (14%) of corrole C2-PI. Rf =0.5 (silica, CH2Cl2); 1H NMR
(500 MHz, CDCl3) d=ꢀ3–ꢀ1 (sbr, 3H; NH), 0.84 (t, J=6.2 Hz, 6H; 2
CH3), 1.20–1.40 (m, 16H; alkyl), 1.85–1.95 (m, 2H; alkyl), 2.22–2.32 (m,
2H; alkyl), 5.15–5.25 (m, 1H; CH), 5.62 (s, 2H; CH2), 7.60 (t, J=8 Hz,
2H; C6H3Cl2), 7.72 (d, J=8 Hz, 4H; C6H3Cl2), 8.09, 8.25 (AA’BB’, J=
6.5 Hz, 22H; C6H4), 8.28–8.70 (m, 14H; 8H; C20H8 +6H; b-H),
8.97 ppm (d, J=4 Hz, 2H; b-H); labs (toluene, e)=413 (113), 428 (104),
459 (22.2), 492 (51.7), 528 (85.3), 561 (18.5), 611 (11.5), 640 nm (6.6
10ꢀ3); ESI-LR obsd: 1246.3 [M++H]; elemental analysis calcd (%) for
C75H58Cl4N6O4: C 72.12, H 4.68, N 6.73; found: C 72.24, H 4.87, N 6.58;
4’-(1,3-Dioxolan-2-yl)biphenyl-4-carbonitrile (12): 4’-Formylbiphenyl-4-
carbonitrile (11, 1.45 g, 7.00 mmol) and ethylene glycol (1.74 g,
28.0 mmol) in toluene (50 mL) was allowed to react analogously to 2 and
was crystallized from hexane/ethanol 5:1. Yield 610 mg (35%) colorless
1
crystalline solid, m.p. 170–1718C; H NMR (200 MHz, CDCl3, 258C): d=
4.02–4.21 (m, 4H; 2CH2O), 5.87 (s, 1H; CH), 7.60–7.76 ppm (m, 8H;
CHarom.); 13C NMR (150 MHz, CDCl3, 258C): d=65.6, 103.5, 111.4, 119.1,
127.4, 127.5, 128.0, 132.8, 138.7, 140.3, 145.5 ppm; IR (ATR): n˜ =3409.2
(w), 3070.0 (w), 2956.2 (m), 2884.5 (s), 2364.8 (w), 2225.5 (vs), 1930.0
(w), 1808.3 (w), 1699.7 (w), 1607.0 (s), 1555.9 (w), 1495.9 (m), 1481.2 (w),
1432.2 (m), 1401.8 (s), 1386.3 (s), 1312.4 (w), 1286.4 (w), 1227.2 (w),
1212.0 (w), 1184.5 (w), 1137.2 (w), 1117.2 (w), 1073.1 (s), 1021.8 (m),
1005.9 (w), 971.7 (m), 942.1 (m), 860.5 (w), 817.4 (vs), 720.2 (w), 689.9
(w), 648.7 cmꢀ1 (w); MS (DEI+/70 eV): m/z (%): 251 (69) [M+], 250
(100) [M+ꢀH], 206 (35) [M+ꢀC2H5O], 190 (21) [M+ꢀC2H5O2], 179 (72)
[M+ꢀC3H4O2], 151 (17) [M+ꢀC4H6NO2], 73 (14) [C3H5O2]; HRMS
(C16H13NO2): m/z: calcd: 251.095; found: 251.095.
4’-(1,3-Dioxolan-2-yl)biphenyl-4-methanamine (13): 4’-(1,3-Dioxolan-2-
yl)-biphenyl-4-carbonitrile (12, 600 mg, 2.39 mmol) in THF (10 mL) and
lithium aluminum hydride (181 mg, 4.78 mmol) in THF (10 mL) were al-
lowed to react analogously to (1,1-dimethoxymethyl)benzylamine (3).
Brown crystalline solid, yield 375 mg (62%); m.p 120–1238C; 1H NMR
(200 MHz, [D6]DMSO, 258C): d=3.75 (s, 2H; CH2), 3.92–4.12 (m, 4H;
2CH2O), 5.77 (s, 1H; CH), 7.39–7.69 ppm (m, 8H; CHarom.); 13C NMR
(100 MHz, [D6]DMSO, 258C, TMS): d=45.9, 65.5, 103.3, 127.0, 127.1,
127.8, 128.3, 137.7, 138.4, 141.6, 144.2 ppm; IR (ATR): n˜ =3380.3 (m),
3029.3 (w), 2953.7 (m), 2887.5 (s), 1915.2 (w), 1613.6 (w), 1562.6 (w),
1498.1 (m), 1432.5 (m), 1403.6 (m), 1382.7 (m), 1346.3 (w), 1310.3 (w),
1277.7 (w), 1205.8 (m), 1183.7 (w), 1114.2 (w), 1074.0 (vs), 1017.0 (m),
1003.6 (w), 964.8 (m), 939.1 (s), 877.8 (w), 838.2 (m), 798.0 (vs),
697.2 cmꢀ1 (w); MS (DEI+/70 eV): m/z (%): 255 (100) [M+], 210 (14)
[M+ꢀC2H5O], 196 (6) [M+ꢀC2H3O2], 182 (42) [M+ꢀC3H5O2], 166 (40)
[M+ꢀC3H7NO2], 152 (15) [M+ꢀC4H9NO2], 106 (18) [M+ꢀC9H9O2] , 73
(25) [C3H5O2]; HRMS (C16H17NO2): m/z: calcd: 255.126; found: 255.126.
10-[(4-[9-(1-Hexylheptyl)-1,3,8,10-tetraoxo-3,8,9,10-tetrahydro-1H-
anthra[2,1,9-def;6,5,10-d’e’f’]diisoquinoline-2-ylmethyl]phenyl)]-5,15-bis-
(pentafluorophenyl)corrole (C3-PI): Pentafluorophenyldipyrromethane
(16) (250 mg, 0.8 mmol) and aldehyde 5 (276 mg, 0.4 mmol) were dis-
solved in CH2Cl2 (6 mL). TFA (12 mL, 1.6 mmol) was added, and the mix-
ture was stirred at room temperature. After 20 min Et3N (22 mL,
0.16 mmol) was added followed by CH2Cl2 (14 mL). DDQ (590 mg,
2.6 mmol) was dissolved in toluene/CH2Cl2 (1:3, 20 mL) and both mix-
tures were added simultaneously to vigorously stirred CH2Cl2 (20 mL).
After 15 min the reaction mixture was concentrated and was purified by
chromatography (DCVC, silica, CH2Cl2). After evaporation, the residue
was dissolved in THF and loaded on an SEC column (THF). The corrole
fraction was collected, evaporated, refluxed with MeOH, and collected
by vacuum filtration to afford 76 mg (15%) of corrole C3-PI. Rf (silica,
CH2Cl2)=0.43; 1H NMR (500 MHz, CDCl3): d=(ꢀ3)–(ꢀ1) (sbr, 3H;
NH), 0.83 (t, J=7 Hz, 6H; 2CH3), 1.20–1.40 (m, 16H; alkyl), 1.85–1.95
(m, 2H; alkyl), 2.22–2.32 (m, 2H; alkyl), 5.10–5.20 (m, 1H; CH), 5.50
(sbr, 2H; CH2), 8.09, 8.25 (AA’BB’, J=6.5 Hz, 22H; C6H4), 8.28–8.70
4’-[9-(1-Hexylheptyl)-1,3,8,10-tetraoxo-3,8,9,10-tetrahydro-1H-
anthra[2,1,9-def;6,5,10-d’e’f’]diisoquinoline-2-ylmethyl]biphenyl-4-carbal-
180
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2008, 14, 169 – 183